🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1 open-label, study designed to characterize the safety, to...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2024-11-06
Trial ID
NCT05629546
Treatments Being Tested
The main purpose of this study is to explore if the combination of autologo...
Status
Unknown
Location
Southwest Hospital of Third Millitary Medical University
Start Date
2016-03
Trial ID
NCT02734524
Treatments Being Tested
Targeted Natural Killer (NK) cell based adoptive immunotherapy for the trea...
Status
Completed
Location
Klinikum rechts der Isar, Strahlentherapie und Radiologische Onkologie
Start Date
2014-03
Trial ID
NCT02118415
Treatments Being Tested
This phase I trial studies the side effects and best dose of expanded natur...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-03-17
Trial ID
NCT02271711
Treatments Being Tested
This study represents a phase I clinical trial that utilizes natural killer...
Status
Recruiting
Location
Cipto Mangunkusumo General Hospital
Start Date
2022-08-29
Trial ID
NCT06044506
Treatments Being Tested
This study aims to determine the safety and efficacy of expanded activated ...
Status
Unknown
Location
National University Hospital
Start Date
2015-07
Trial ID
NCT02507154
Treatments Being Tested
Natural killer (NK) cells can kill a broad array of tumor cells in a non-ma...
Status
Unknown
Location
the First Hospital of Jilin University
Start Date
2018-04-01
Trial ID
NCT03410368
Treatments Being Tested
Multiple Myeloma (MM) is a lethal disease and at present no available treat...
Status
Unknown
Location
Karolinska University Hospital
Start Date
2014-01-01
Trial ID
NCT04558853
Treatments Being Tested
This phase I/IIa trial studies the side effects and best dose of a type of ...
Status
Withdrawn
Location
Roswell Park Cancer Institute
Start Date
2023-12-15
Trial ID
NCT03735589
Treatments Being Tested
The objective of the study is to evaluate tolerability and safety of CBT101...
Status
Completed
Location
CHA Bundang Medical Center
Start Date
2020-09-21
Trial ID
NCT04557306
Treatments Being Tested